bf/NASDAQ:ADAP_icon.png

COM:ADAPTIMMUNE

Adaptimmune Therapeutics plc

  • Stock

USD

Last Close

0.64

22/11 21:00

Market Cap

293.91M

Beta: -

Volume Today

1.34M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
51.11K
-
51.11K
0%
1.88M
3,578.61%
2.42M
28.91%
1.27M
47.47%
1.77M
39.24%
1.04M
41.16%
639.50K
-
average payables
1.46M
-
1.50M
2.20%
6.66M
345.34%
9.86M
48.00%
6.23M
36.84%
5.22M
16.22%
6.37M
22.09%
7.25M
13.78%
6.43M
11.28%
6.44M
0.12%
average receivables
1.40M
-
3.67M
161.85%
3.46M
5.57%
843K
75.66%
199K
76.39%
-633.50K
418.34%
-660K
4.18%
445.50K
167.50%
4.09M
818.86%
4.13M
0.84%
book value per share
0.01
-
7.25
127,752.41%
2.35
67.65%
2.31
1.66%
2.54
9.83%
1.18
53.54%
2.40
103.35%
1.32
44.81%
0.51
61.58%
0.00
99.99%
capex per share
-0.00
-
-0.14
4,083.66%
-0.18
26.50%
-0.28
57.47%
-0.05
83.00%
-0.03
39.42%
-0.02
30.35%
-0.06
176.29%
-0.18
227.34%
capex to depreciation
-5.79
-
-6.97
20.43%
-3.89
44.20%
-4.61
18.54%
-0.60
86.93%
-0.38
36.34%
-0.38
0.29%
-1.34
249.42%
-4.90
266.12%
capex to operating cash flow
-0.04
-
0.16
500.90%
0.27
70.07%
0.46
73.49%
0.05
90.21%
0.03
39.42%
0.05
98.46%
-0.82
1,609.32%
0.21
125.63%
capex to revenue
-2.40
-
-0.48
80.12%
-0.90
88.96%
-0.66
26.58%
-0.08
88.03%
-2.74
3,362.80%
-0.73
73.20%
-1.43
94.50%
-1.10
23.29%
cash per share
0.12
-
7.95
6,482.16%
2.56
67.74%
2.37
7.62%
2.11
11.06%
0.85
59.50%
2.58
202.99%
2.37
8.22%
1.27
46.49%
0.00
99.99%
days of inventory on hand
days payables outstanding
days sales outstanding
1.14K
-
185.39
83.74%
38.05
79.48%
1.99
94.78%
1.18
40.74%
-474.63
40,400.89%
12.82
102.70%
44.64
248.24%
99.96
123.94%
4.97
95.03%
debt to assets
0.07
-
0.14
-
0.05
62.52%
0.05
3.20%
0.07
29.35%
0.09
27.27%
debt to equity
0.10
-
0.21
-
0.07
66.25%
0.12
77.95%
0.28
127.93%
0.64
126.60%
dividend yield
earnings yield
-0.00
-
-0.03
1,660.80%
-0.25
658.59%
-0.12
52.18%
-0.17
42.85%
-1.09
538.44%
-0.17
84.44%
-0.27
59.71%
-0.70
159.81%
-0.00
99.98%
enterprise value
6.74B
-
426.86M
93.67%
127.90M
70.04%
627.61M
390.69%
628.37M
0.12%
101.01M
83.93%
734.71M
627.38%
459.79M
37.42%
150.41M
67.29%
956.59B
635,903.16%
enterprise value over ebitda
-477.71
-
-19.55
95.91%
-1.84
90.59%
-8.34
353.36%
-8.43
1.04%
-0.77
90.90%
-5.84
661.77%
-2.95
49.43%
-0.95
67.75%
-8.30K
871,535.75%
ev to operating cash flow
181.14
-
-13.04
107.20%
-2.66
79.64%
-11.56
335.16%
-6.02
47.91%
-0.90
85.09%
-13.71
1,427.03%
42.85
412.59%
-1.06
102.48%
-6.79K
639,916.56%
ev to sales
11.15K
-
39.81
99.64%
9.01
77.37%
16.59
84.15%
10.56
36.34%
90.02
752.52%
185.63
106.19%
74.77
59.72%
5.54
92.59%
15.87K
286,328.79%
free cash flow per share
0.08
-
-1.06
1,355.32%
-0.86
18.58%
-0.90
4.76%
-1.12
24.18%
-1.10
1.70%
-0.40
63.98%
0.01
103.15%
-1.06
8,609.36%
-0.00
99.99%
free cash flow yield
0.01
-
-0.06
1,195.75%
-0.21
268.50%
-0.14
36.49%
-0.19
44.27%
-0.92
371.00%
-0.07
91.98%
0.00
104.53%
-0.73
21,956.22%
-0.00
99.98%
graham net net
-0.00
-
6.91
703,130.91%
1.61
76.66%
1.50
6.87%
1.81
20.25%
0.30
83.51%
1.82
511.28%
0.68
62.45%
-0.23
133.43%
-0.00
99.97%
graham number
0.06
-
9.92
15,959.46%
7.31
26.36%
6.44
11.93%
7.48
16.21%
5.88
21.32%
7.02
19.21%
5.49
21.69%
3.42
37.66%
0.00
99.99%
income quality
-2.59
-
1.38
153.34%
0.67
51.29%
0.77
15.08%
1.09
41.13%
0.82
24.95%
0.41
49.78%
-0.07
116.47%
0.86
1,362.54%
1.24
44.39%
intangibles to total assets
0
-
0.00
Infinity%
0.01
814.92%
0.00
12.05%
0.01
11.93%
0.01
127.46%
0.00
68.33%
0.00
44.46%
0.00
36.90%
0.00
13.11%
interest coverage
-2.11K
-
45.39
102.15%
-36.17
-
-219.06
505.61%
162.99
-
interest debt per share
0.00
-
-0.01
88,643.65%
0.23
1,736.01%
0.03
89.09%
0.00
84.78%
0.24
6,182.20%
0.17
31.38%
0.16
1.79%
0.14
16.24%
0.00
99.98%
inventory turnover
invested capital
0.10
-
0.21
-
0.07
66.25%
0.12
77.95%
0.28
127.93%
0.64
126.60%
market cap
6.80B
-
655.92M
90.35%
286.68M
56.29%
587.44M
104.91%
559.99M
4.67%
125.96M
77.51%
767.88M
509.62%
584.27M
23.91%
235.36M
59.72%
956.71B
406,382.95%
net current asset value
979.32K
-
254.04M
25,840.25%
130.38M
48.68%
152.02M
16.60%
201.24M
32.38%
62.58M
68.90%
288.24M
360.56%
151.87M
47.31%
8.33M
94.51%
-35.55M
526.68%
net debt to ebitda
3.63
-
10.49
188.91%
2.28
78.23%
-0.53
123.38%
-0.92
71.75%
0.19
120.65%
0.26
39.22%
0.80
203.27%
0.54
32.71%
1.03
91.57%
net income per share
-0.03
-
-0.60
1,917.22%
-1.01
67.61%
-0.80
21.13%
-0.98
22.97%
-1.31
33.24%
-0.91
30.12%
-1.01
11.12%
-1.03
1.15%
-0.00
99.99%
operating cash flow per share
0.09
-
-0.91
1,143.58%
-0.68
25.62%
-0.62
9.23%
-1.07
73.54%
-1.07
0.00%
-0.38
64.90%
0.07
118.31%
-0.88
1,377.09%
-0.00
99.99%
payables turnover
receivables turnover
0.32
-
1.97
515.05%
9.59
387.26%
183.66
1,814.42%
309.92
68.75%
-0.77
100.25%
28.47
3,802.74%
8.18
71.28%
3.65
55.34%
73.42
1,910.85%
research and ddevelopement to revenue
20.72
-
2.16
89.56%
4.49
107.69%
2.31
48.59%
1.65
28.50%
86.90
5,162.03%
23.13
73.38%
18.07
21.91%
4.70
73.96%
2.10
55.39%
return on tangible assets
-0.23
-
-0.07
68.60%
-0.31
327.15%
-0.25
18.32%
-0.35
38.43%
-0.76
120.41%
-0.29
62.15%
-0.34
16.56%
-0.50
49.29%
-0.40
19.92%
revenue per share
0.00
-
0.30
20,945.80%
0.20
33.05%
0.43
114.49%
0.61
42.02%
0.01
98.25%
0.03
159.92%
0.04
42.05%
0.17
326.71%
0.00
99.97%
roe
-5.27
-
-0.08
98.42%
-0.43
418.08%
-0.35
19.80%
-0.39
11.96%
-1.11
186.76%
-0.38
65.64%
-0.77
101.33%
-2.02
163.27%
-2.88
42.61%
roic
-5.27
-
-0.08
98.46%
-0.40
398.67%
-0.40
0.94%
-0.34
16.15%
-0.80
139.18%
-0.34
57.15%
-0.63
84.69%
-1.30
104.85%
-1.27
2.70%
sales general and administrative to revenue
4.51
-
1.06
76.60%
1.63
54.77%
0.82
49.70%
0.73
10.88%
38.67
5,177.93%
11.57
70.08%
9.32
19.45%
2.33
74.95%
1.22
47.77%
shareholders equity per share
0.01
-
7.25
127,752.41%
2.35
67.65%
2.31
1.66%
2.54
9.83%
1.18
53.54%
2.40
103.35%
1.32
44.81%
0.51
61.58%
0.00
99.99%
stock based compensation to revenue
0.58
-
0.39
31.85%
0.62
57.88%
0.29
54.04%
0.27
4.65%
9.85
3,518.03%
2.63
73.29%
3.35
27.51%
0.67
79.97%
0.20
70.93%
tangible asset value
2.41M
-
259.43M
10,664.83%
164.87M
36.45%
201.65M
22.30%
245.41M
21.70%
121.44M
50.52%
339.50M
179.56%
204.96M
39.63%
81.44M
60.27%
39.18M
51.88%
tangible book value per share
0.01
-
7.25
127,664.90%
2.33
67.87%
2.29
1.55%
2.52
9.89%
1.16
54.09%
2.38
105.98%
1.32
44.80%
0.51
61.60%
0.00
99.99%
working capital
979.32K
-
268.35M
27,301.44%
158.48M
40.94%
155.87M
1.65%
206.66M
32.58%
86.15M
58.31%
359.08M
316.82%
352.92M
1.72%
190.87M
45.92%
134.76M
29.39%

All numbers in USD (except ratios and percentages)